Business Ethics of Innovation (Ethics of Science and by Dirk Matten, Jeremy Moon, Michael J. Selgelid,

By Dirk Matten, Jeremy Moon, Michael J. Selgelid,

Show description

Read Online or Download Business Ethics of Innovation (Ethics of Science and Technology Assessment) PDF

Best scientific-popular books

Living and Studying Abroad: Research and Practice

Michael Byram is Professor of schooling at Durham college the place he has taught trainee academics, and researched language instructing and the event of dwelling overseas on language scholars in larger schooling. he's additionally Adviser to the Council of Europe Language coverage department. Anwei Feng lectures and supervises schooling doctoral scholars at Durham collage.

Extra info for Business Ethics of Innovation (Ethics of Science and Technology Assessment)

Sample text

University of California Press Francis LP, Battin MP, Jacobson JA, Smith CB, Botkin J (2005) How Infectious Disease Got Left Out – And What this Ommission Might Have Meant for Bioethics. Bioethics 19, 4:307–322 Friedman M (1970) The Social Responsibility of Business is to Increase its Profits. The New York Times Magazine. September 13:33, 122–126 Garrett L (1994) The Coming Plague: Newly Emerging Diseases in a World Out of Balance. New York. Penguin Knobler SL, Lemon SM, Najafi M, Burroughs T (eds) (2003) The Resistance Phenomenon in Microbes and Infectious Disease Vectors: Implications for Human Health and Strategies for Containment.

Patient demand and physician prescription are increasingly also influenced by aggressive marketing of the pharmaceutical industry (Smith et al. 2004:12). Another cause of drug resistance is patients’ failure often fail to complete prescribed treatment regimens. While this itself promotes resistance, matters are made worse when leftover pills are saved and then used for “self-medication” later (Levy 1992). The fact that antibiotics are poorly understood by the lay public comes into play both in the case of self-medication and when patients demand inappropriate prescriptions from willing physicians.

This is one reason why physicians emphasize the importance of completing our treatments by taking all the pills provided. And this is why “noncompliant patients” are so often blamed for the problem of drug resistance. The failure to complete a full course of treatment, however, is not always the fault of the patient. “Noncompliance”, according to Paul Farmer, is usually a matter of ability rather than agency: “Throughout the world, those least likely to comply are those least able to comply” (Farmer 1999:255; 2003).

Download PDF sample

Rated 4.05 of 5 – based on 38 votes